Concepedia

Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients

Rebecca Levin-Epstein, Ryan Cook, J.K. Wong, Richard G. Stock, D. Jeffrey Demanes, Sean P. Collins, Nima Aghdam, Simeng Suy, C.A. Mantz, Alan J. Katz,

Radiotherapy and Oncology · 2020 · 26 citations · 20 references

DOI

Concepts

References

20

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference

Mack Roach, Gerald E. Hanks, Howard D. Thames et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 2.7K citations

, , +14

Estimation of Extended Mixed Models Using Latent Classes and Latent Processes: The <i>R</i> Package <b>lcmm</b>

Journal of Statistical Software · 2017 · 993 citations · Full text

, , +16

Estimation of extended mixed models using latent classes and latent processes: the R package lcmm

RePEc: Research Papers in Economics · 2015 · 765 citations · Full text

, , +16

10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy

Peter Grimm, John C. Blasko, John E. Sylvester et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 450 citations

, , +13

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer

Amar U. Kishan, Audrey Dang, Alan J. Katz et al. · JAMA Network Open · 2019 · 314 citations · Full text

, , +17